longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Merck(MKKGY.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Merck KGaA Earnings Call Signals Cautious Upswing

Tip Ranks·05/15/2026 08:45
US
MKKGY
+2.91%
Tip Ranks·05/15/2026 08:45
US
MKKGY
+2.91%

European shares lifted by miners and tech; Middle East in focus

Businesstimes News·05/14/2026 05:55
US
MRK
-1.09%
US
MKKGY
+2.91%
DE
ALV
0.00%
Businesstimes News·05/14/2026 05:55
US
MRK
-1.09%
US
MKKGY
+2.91%
DE
ALV
0.00%

Merck KGaA Lifts FY26 Outlook, Backs Positive Mid-term View, Despite Weak Q1; Stock Gains

rttnews·05/13/2026 19:04
DE
MRK
0.00%
US
MKKGY
+2.91%
rttnews·05/13/2026 19:04
DE
MRK
0.00%
US
MKKGY
+2.91%

European shares rise as oil prices slip on fragile US-Iran ceasefire

Businesstimes News·05/13/2026 15:36
DE
ALV
0.00%
DE
MRK
0.00%
Businesstimes News·05/13/2026 15:36
DE
ALV
0.00%
DE
MRK
0.00%

A Look At Merck KGaA (XTRA:MRK) Valuation After Advancing Enpatoran To Global Phase 3 Lupus Trials

Simplywall·05/08/2026 02:14
DE
MRK
0.00%
US
MKKGY
+2.91%
Simplywall·05/08/2026 02:14
DE
MRK
0.00%
US
MKKGY
+2.91%

Merck KGaA (0O14) Gets a Buy from UBS

Tip Ranks·05/07/2026 17:15
US
MKKGY
+2.91%
DE
MRK
0.00%
Tip Ranks·05/07/2026 17:15
US
MKKGY
+2.91%
DE
MRK
0.00%

J.P. Morgan Sticks to Their Buy Rating for Merck KGaA (0O14)

Tip Ranks·05/05/2026 21:37
DE
MRK
0.00%
US
MKKGY
+2.91%
Tip Ranks·05/05/2026 21:37
DE
MRK
0.00%
US
MKKGY
+2.91%

Kepler Capital Reaffirms Their Buy Rating on Merck KGaA (0O14)

Tip Ranks·05/03/2026 17:05
US
MKKGY
+2.91%
Tip Ranks·05/03/2026 17:05
US
MKKGY
+2.91%
© 2026 Longbridge|Disclaimer

Event Tracking

May13
Merck released FY2026 Q1 earnings on May 13 Pre-Market (EST), actual revenue USD 5.883 B (forecast USD 5.824 B), actual EPS USD 0.3483
13:30
Merck Announces Q1 2026 Earnings Beat Expectations
05:25
May6
Merck to Release FY2026 Q1 Earnings on May 13 Pre-Market EST, Forecast Revenue USD 5.976 B
00:19
Apr30
Merck Starts Phase III ELOWEN Project to Treat Lupus Patients
12:21
Mar5
Merck released FY2025 Annual Earnings on March 5 Pre-Market (EST), actual revenue USD 24.31 B (forecast USD 24.88 B), actual EPS USD 1.3823
14:30
Merck released FY2025 Q4 earnings on March 5 Pre-Market EST, actual revenue USD 6.165 B (forecast USD 6.221 B), actual EPS USD 0.1723
14:30

Schedules & Filings

Schedules
Filings
May13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 5.883 B, Net Income 755.67 M, EPS 0.3483

May6
Distribution Plan(EST)

Cash dividend 0.5147 USD

Apr28
Distribution Plan(EST)

Cash dividend 0.5147 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More